Bioinvent International AB operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioinvent International AB with three other
companies in this sector in Sweden:
sales of 35.60 million Swedish Kronor [US$3.83 million]
PledPharma AB (publ)
(28.21 million Swedish Kronor [US$3.03 million]
(34.57 million Swedish Kronor [US$3.71 million]
Bioinvent International AB reported sales of SEK 38.55 million (US$4.14 million)
December of 2018.
decrease of 14.4%
versus 2017, when the company's sales were SEK 45.01 million.